Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025
Escudier, Bernard, Motzer, Robert J, Sharma, Padmanee, Wagstaff, John, Plimack, Elizabeth R, Hammers, Hans J, Donskov, Frede, Gurney, Howard, Sosman, Jeffrey A, Zalewski, Pawel G, Harmenberg, Ulrika, McDermott, David F, Choueiri, Toni K, Richardet, Martin, Tomita, Yoshihiko, Ravaud, Alain, Doan, Justin, Zhao, Huanyu, Hardy, Helene, George, Saby
Published in European urology (01.09.2017)
Published in European urology (01.09.2017)
Get full text
Journal Article
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti‐Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma
Choueiri, Toni K., Michaelson, M. Dror, Posadas, Edwin M., Sonpavde, Guru P., McDermott, David F., Nixon, Andrew B., Liu, Yingmiao, Yuan, Zhenhua, Seon, Ben K., Walsh, Meghara, Jivani, Manoj A., Adams, Bonne J., Theuer, Charles P.
Published in The oncologist (Dayton, Ohio) (01.02.2019)
Published in The oncologist (Dayton, Ohio) (01.02.2019)
Get full text
Journal Article
Multicenter phase ii trial of high-dose imatinib mesylate in metastatic melanoma : Significant toxicity with no clinical efficacy
WYMAN, Ken, ATKINS, Michael B, PRIETO, Victor, ETON, Omar, MCDERMOTT, David F, HUBBARD, Francie, BYRNES, Christine, SANDERS, Kathleen, SOSMAN, Jeffrey A
Published in Cancer (01.05.2006)
Published in Cancer (01.05.2006)
Get full text
Journal Article
Phase I Trial of Twice-Weekly Intravenous Interleukin 12 in Patients with Metastatic Renal Cell Cancer or Malignant Melanoma: Ability to Maintain IFN-γ Induction Is Associated with Clinical Response
Gollob, J A, Mier, J W, Veenstra, K, McDermott, D F, Clancy, D, Clancy, M, Atkins, M B
Published in Clinical cancer research (01.05.2000)
Get full text
Published in Clinical cancer research (01.05.2000)
Journal Article
Circulating mir-21 and mir-378 are predictive of progression-free survival (PFS) in patients treated with everolimus in metastatic renal cell cancer (mRCC)
Chen, James Lin, Rathmell, Kimryn, McDermott, David F., Stadler, Walter Michael
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Michaelson MD, McKay RR, Werner L, Atkins MB, Van Allen EM, Olivier KM, Song J, Signoretti S, McDermott DF, Choueiri TK.Cancer. 2015 Oct 1;121(19):3435-43. [Epub 2015 Jun 8]. doi: 10.1002/cncr.29503
Jay, Raman, M.D, McKay, RR, Werner, L, Atkins, MB, Van Allen, EM, Olivier, KM, Song, J, Signoretti, S, McDermott, DF, Choueiri, TK
Published in Urologic oncology (01.03.2017)
Published in Urologic oncology (01.03.2017)
Get full text
Journal Article
Phase I Trial of Concurrent Twice-Weekly Recombinant Human Interleukin-12 Plus Low-Dose IL-2 in Patients With Melanoma or Renal Cell Carcinoma
GOLLOB, Jared A, VEENSTRA, Korina G, PARKER, Robert A, MIER, James W, MCDERMOTT, David F, CLANCY, Daniel, TUTIN, Linda, KOON, Henry, ATKINS, Michael B
Published in Journal of clinical oncology (01.07.2003)
Published in Journal of clinical oncology (01.07.2003)
Get full text
Journal Article
A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma
Atkins, Michael B, Gollob, Jared A, Sosman, Jeffrey A, McDermott, David F, Tutin, Linda, Sorokin, Patricia, Parker, Robert A, Mier, James W
Published in Clinical cancer research (01.10.2002)
Get full text
Published in Clinical cancer research (01.10.2002)
Journal Article
Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma
Fallick, M L, McDermott, D F, LaRock, D, Long, J P, Atkins, M B
Published in The Journal of urology (01.11.1997)
Published in The Journal of urology (01.11.1997)
Get more information
Journal Article
PCN50 COSTS OF TREATMENT WITH ANGIOGENESIS INHIBITORS (AIS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A MEDICAL CHART REVIEW STUDY
Oh, WK, McDermott, DF, Duh, MS, Antràs, L, Chen, K, Sarda, SP, Luka, A, Whittemore, S, Ramamurthy, P, Neary, MP, Choueiri, TK
Published in Value in health (2010)
Published in Value in health (2010)
Get full text
Journal Article
A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma
McDermott, D F, Mier, J W, Lawrence, D P, van den Brink, M R, Clancy, M A, Rubin, K M, Atkins, M B
Published in Clinical cancer research (01.06.2000)
Get full text
Published in Clinical cancer research (01.06.2000)
Journal Article
Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis
MIRALLES, G. D, STOECKLE, M. Y, MCDERMOTT, D. F, FINKELMAN, F. D, MURRAY, H. W
Published in Infection and Immunity (01.03.1994)
Published in Infection and Immunity (01.03.1994)
Get full text
Journal Article
Case 1. Disseminated cutaneous plasmacytomas treated with total skin electron radiotherapy
FLOYD, Scott R, PANTANOWITZ, Liron, MCDERMOTT, David F, YANNUCCI, Jennifer, DRIVER, Jane A, STEVENSON, Mary Ann, SMITH, Benjamin D, WILSON, Lynn D, RICHARDSON, Paul G
Published in Journal of clinical oncology (01.05.2005)
Published in Journal of clinical oncology (01.05.2005)
Get full text
Journal Article
Role and effect of IL-2 in experimental visceral leishmaniasis
Murray, HW, Miralles, GD, Stoeckle, MY, McDermott, DF
Published in The Journal of immunology (1950) (15.07.1993)
Published in The Journal of immunology (1950) (15.07.1993)
Get full text
Journal Article
A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor
MCDERMOTT, D. F, TREHU, E. G, MIER, J. W, SORCE, D, RAND, W, RONAYNE, L, KAPPLER, K, CLANCY, M, KLEMPNER, M, ATKINS, M. B
Published in Clinical cancer research (01.05.1998)
Get full text
Published in Clinical cancer research (01.05.1998)
Journal Article